All Stories

  1. Improving Time to Kidney Transplant Listing: A Single Center Quality Improvement Initiative
  2. Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with and without Advanced CKD
  3. Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis
  4. Sensing Dying Cells in Health and Disease: The Importance of Kidney Injury Molecule-1
  5. Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
  6. CENtral blood pressure Targeting: a pragmatic RAndomized triaL in advanced Chronic Kidney Disease (CENTRAL-CKD): A Clinical Research Protocol
  7. Electronic Decision Support for Deprescribing in Patients on Hemodialysis: Clinical Research Protocol for a Prospective, Controlled, Quality Improvement Study
  8. Transition From Pediatric to Adult Nephrology Care: Program Report of a Single-Center Experience
  9. Volume Status Assessment by Lung Ultrasound in End-Stage Kidney Disease: A Systematic Review
  10. Lived Experiences of Hemodialysis Health Care Workers during the COVID-19 Pandemic: A Qualitative Study from the Quebec Renal Network
  11. Identifying Modifiable System-Level Barriers to Living Donor Kidney Transplantation
  12. Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis Patients
  13. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+T cell profile
  14. Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans
  15. Lived Experiences of Patients Receiving Hemodialysis during the COVID-19 Pandemic: A Qualitative Study from the Quebec Renal Network
  16. SARS-CoV-2 Vaccine Mandates for Patients on the Kidney Transplant Waitlist
  17. Accessing hemodialysis clinics during the COVID-19 pandemic
  18. Five Things to Know About Intradialytic Hypertension
  19. Opioid prescribing practices in chronic kidney disease: a population-based cohort study
  20. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion
  21. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis
  22. Recombinant apoptosis inhibitor of macrophage protein reduces delayed graft function in a murine model of kidney transplantation
  23. Short-term antibody response and tolerability after one dose of BNT162b2 vaccine in patients receiving hemodialysis: A report from the Quebec Renal Network COVID-19 study
  24. Quality of Life and Hemodynamic Effects of Switching From Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort Study
  25. Re-Envisioning the Canadian Nephrology Trials Network: A Can-SOLVE-CKD Stakeholder Meeting of Patient Partners and Researchers
  26. Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study
  27. COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter
  28. Management of Outpatient Hemodialysis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team
  29. Proceedings From a Canadian Nephrology Forum: Nephrology Is Back
  30. Use of the FRAIL Questionnaire in Patients With End-Stage Kidney Disease
  31. Effects of Frequent Hemodialysis on Perceived Caregiver Burden in the Frequent Hemodialysis Network Trials
  32. The Author Replies:
  33. The Authors Reply
  34. Hypertension in pregnancy afterEscherichia coliO157:H7 gastroenteritis: a cohort study
  35. Canadian Society of Nephrology Guidelines for the Management of Patients With ESRD Treated With Intensive Hemodialysis
  36. Dialysate Calcium Concentration and Mineral Metabolism in Long and Long-Frequent Hemodialysis: A Systematic Review and Meta-analysis for a Canadian Society of Nephrology Clinical Practice Guideline
  37. Vascular Access for Intensive Maintenance Hemodialysis: A Systematic Review for a Canadian Society of Nephrology Clinical Practice Guideline
  38. Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium
  39. Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis
  40. Risk of Vascular Access Complications with Frequent Hemodialysis
  41. A multinational cohort study of in-center daily hemodialysis and patient survival
  42. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials
  43. Case report: Atenolol overdose successfully treated with hemodialysis
  44. Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis
  45. Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis
  46. Early dialysis
  47. Patient experiences and preferences on short daily and nocturnal home hemodialysis
  48. Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis
  49. Survival with Three-Times Weekly In-Center Nocturnal Versus Conventional Hemodialysis
  50. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
  51. Urine Volume and Change in Estimated GFR in a Community-Based Cohort Study
  52. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada
  53. Dipstick Proteinuria as a Screening Strategy to Identify Rapid Renal Decline
  54. Peritoneal dialysis vs hemodialysis: time to end the debate?
  55. Hemodialysis in a Satellite Unit: Clinical Performance Target Attainment and Health-Related Quality of Life
  56. Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials
  57. Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011
  58. Design and Rationale of Health-Related Quality of Life and Patient-Reported Outcomes Assessment in the Frequent Hemodialysis Network Trials
  59. International quotidian dialysis registry: Annual report 2010
  60. Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study
  61. Opioid and Benzodiazepine Use in End-Stage Renal Disease: A Systematic Review
  62. Recruitment and Training for Home Hemodialysis: Experience and Lessons from the Nocturnal Dialysis Trial
  63. Risk of Pregnancy-Related Hypertension Within 5 Years of Exposure to Drinking Water Contaminated With Escherichia coli O157:H7
  64. Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription
  65. International quotidian dialysis registry: Annual report 2009
  66. Factors that led to the Walkerton tragedy
  67. Relationship between Escherichia coli O157:H7 and diabetes mellitus
  68. Renal prognosis of toxigenic Escherichia coli infection
  69. Risk of pregnancy-related hypertension within five years of exposure to bacteria-contaminated drinking water
  70. TTP/HUS: observational studies generate hypotheses that lead to randomized controlled trials
  71. PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Frequent Hemodialysis and Psychosocial Function
  72. Elevated Blood Pressure in Relation to Overweight and Obesity Among Children in a Rural Canadian Community
  73. The International Quotidian Dialysis Registry: Annual report 2008
  74. The International Quotidian Hemodialysis Registry: Rationale and challenges
  75. Can Extracellular Fluid Volume Expansion in Hemodialysis Patients Be Safely Reduced Using the Hemocontrol Biofeedback Algorithm? A Randomized Trial
  76. Albuminuria and Estimated GFR 5 Years After Escherichia coli O157 Hemolytic Uremic Syndrome: An Update
  77. Excessive fluid intake as a novel cause of proteinuria
  78. The International Quotidian Dialysis Registry: Annual Report 2007
  79. Frequent Hemodialysis Network (FHN) randomized trials: Study design
  80. The International Quotidian Dialysis Registry: Annual report 2006
  81. Randomized Trials of Frequent Hemodialysis – Infinite Possibilities
  82. Diabetes in Diarrhea-Associated Hemolytic Uremic Syndrome: A Systematic Review and Meta-Analysis
  83. Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water
  84. The International Quotidian Dialysis Registry: Annual report 2005
  85. Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination
  86. Is more frequent hemodialysis beneficial and what is the evidence?
  87. The International Quotidian Hemodialysis Registry: Rationale and methods
  88. Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic Syndrome
  89. Adequacy of quotidian hemodialysis
  90. The impact of quotidian hemodialysis on nutrition
  91. Volume control and blood pressure management in patients undergoing quotidian hemodialysis